Edinburgh Genomics has recently acquired the new Revio system, a state-of-the-art long-read sequencer developed by Pacific Biosciences (PacBio). This acquisition has been made possible through a significant grant from the Biotechnology and Biological Sciences Research Council (BBSRC).

The Revio system can read long sections of genetic material, enabling scientists to study genomes and transcriptomes in much greater detail. It represents a revolutionary advancement in High Fidelity (HiFi) long-read sequencing, providing a 15-fold increase in capacity at lower costs. Additionally, the system incorporates advanced deep learning techniques to enhance the accuracy of the HiFi reads. Consequently, this new technology maximises cost-effectiveness, facilitates greater sequencing depth, and enables precise identification of challenging sequencing genetic regions.

We are thrilled to bring this cutting-edge technology to the University of Edinburgh, as it empowers Edinburgh Genomics to generate high-quality reference genomes and pangenomes, comprehensively characterise full-length transcriptomes, explore genome methylation, and study microorganisms within complex microbial communities. With this powerful new tool at our disposal, we eagerly anticipate supporting bioscience research that demands high-quality comprehensive genomic data.

The acquisition of the Revio system marks an exciting chapter in our scientific journey, and we are eager to collaborate with researchers from diverse fields to drive groundbreaking discoveries and further the frontiers of genomics.

EdinburghGenomics #BioscienceResearch #LongReadSequencing #Genomics #PacBioRevio